Search results
Results from the WOW.Com Content Network
Its stock is a tracking stock of Applera, along with the tracking stock of Applera's larger Applied Biosystems Group business unit. Celera sequenced the human genome at a fraction of the cost of the publicly funded Human Genome Project (HGP), using about $300 million of private funding versus approximately $3 billion of taxpayer dollars.
The recapitalization of the company resulted in issuance of the two new classes of common stock, called PE Corporation-PE Biosystems Group Common Stock and PE Corporation-Celera Genomics Group Common Stock. [15] On that date, trading began in both new stocks on the New York Stock Exchange, to great excitement. [7]
On May 6, 1999, the recapitalization of the company resulted in issuance of the two new classes of common stock, called PE Corporation-PE Biosystems Group Common Stock and PE Corporation-Celera Genomics Group Common Stock. [19] On that date, trading began in both new stocks on the New York Stock Exchange, to great excitement. [18]
The statement sent Celera's stock plummeting and dragged down the biotechnology-heavy Nasdaq. The biotechnology sector lost about $50 billion in market capitalization in two days. [citation needed] Although the working draft was announced in June 2000, it was not until February 2001 that Celera and the HGP scientists published details of their ...
PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics.Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others.
Venter (and Smith)'s previous company, Celera Genomics, was a driving force in the race to sequence the human genome. [9] The firm takes its name from the phrase synthetic genomics which is a scientific discipline of synthetic biology related to the generation of organisms artificially using genetic material. [10] [11]
A. A123 Systems; Abcam; Abengoa; Abiomed; Acceleron Pharma; Access Systems Americas; Aclara Biosciences; Acme Packet; Acorda Therapeutics; Actel; Actions Semiconductor
The Otto Celera 500L is a business and utility light aircraft developed by American startup Otto Aviation. By November 2021, 55 successful [ 3 ] test flights had been completed, as introduction is targeted for 2024–2025.